Pevec, D., Novinscak, T., Brcic, L., Sipos, K., Jukic, I., Staresinic, M., Mise, S., Brcic, I., Kolenc, D., Klicek, R., Banic, T., Sever, M., Kocijan, A., Berkopic, L., Radic, B., Buljat, G., Anic, T., Zoricic, I., Bojanic, I., Sikiric, P
Lee JA, Ku Y, Rhyu IC, Chung CP, Park YJ
2007 DOI: 10.1111/j.1600-0625.2007.00576.x PMID: 17542980 Read on PubMed Annals of the New York Academy of Sciences Iamin: a human growth factor with multiple wound-healing properties Pickart L, Lovejoy S 1989 DOI: 10.1111/j.1749-6632.1989.tb55807.x PMID: 2774355 Read on PubMed 10 peer-reviewed references listed
Heffernan 2001b No antibody formation or immunogenic response detected across trials
Duration of Therapy: 10 days Additional Notes: This protocol is designed to be administered up to twice per year
doi: 10.1016/s0254-6272(11)60050-2